BIO Has Big Diversity Goals. Does It Have the Means to Reach Them?
Summary
Whether from embarrassing parties or sobering surveys, the biotech gender gap problem has made plenty of headlines the past couple years.Xconomy reached the chair of BIO’s Workforce Development, Diversity & Inclusion committee Helen Torley to ask these questions.Xconomy talked to Torley about making a business case for diversity, how best to get companies to reach these goals, the risk of tokenism, and more.It’s needed to make drug development successful: a diversity of gender, race, background, skill sets, creating inclusive cultures where the best ideas win in a much broader sense.HT : To continue to highlight the importance of diversity, but also to take a stand with regard to how BIO would expect its members to behave, which in part was coming after PABNAB.
Classifications
AskAI Classifications
LabelsLinked Companies
